We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Depressants.
ipros is IPROS GMS IPROS One of the largest technical database sites in Japan that collects information on.

Depressants - List of Manufacturers, Suppliers, Companies and Products

Depressants Product List

1~5 item / All 5 items

Displayed results

Do you feel down in winter? It's called "winter blues"!

Thorough explanation of causes and countermeasures!

As it gets cold during this time of year, some people may find themselves feeling down, saying things like "I just feel gloomy" or "I have no motivation to do anything..." This might be what is known as "winter blues." It has symptoms similar to depression and is more likely to occur in winter, which is why it is also called "seasonal affective disorder." In this article, we will explain in detail the symptoms, causes, and ways to improve "winter blues." *You can read the continuation of the article through the related link (our company website).

  • Other services
  • others
  • Other office supplies

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Treatment-Resistant Depression

Global Market for Treatment-Resistant Depression: Selective Serotonin Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Esketamine Nasal Spray ...

This research report (Global Treatment Resistant Depression Market) investigates and analyzes the current state and outlook for the global market of treatment-resistant depression over the next five years. It includes information on the overview of the global treatment-resistant depression market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the treatment-resistant depression market include selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, tricyclic antidepressants, and esketamine nasal spray, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for treatment-resistant depression. It also includes the market share of major companies in treatment-resistant depression, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Treating Chronic Depressive Personality Disorder

Global Market for Chronic Depressive Personality Disorder Treatment: Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants, Norepinephrine Reuptake Inhibitors, ...

This research report (Global Chronic Depressive Personality Disorder Treatment) investigates and analyzes the current state and outlook for the global market for chronic depressive personality disorder treatment over the next five years. It includes information on the overview of the global chronic depressive personality disorder treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include selective serotonin reuptake inhibitors, tricyclic antidepressants, norepinephrine reuptake inhibitors, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for chronic depressive personality disorder treatment. It also includes the market share of major companies in chronic depressive personality disorder treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Global Market for Fetal Alcohol Spectrum Disorder (FASD) Treatment

Global Market for Fetal Alcohol Spectrum Disorder (FASD) Treatment: Antidepressants, Stimulants, Muscle Relaxants, Anxiolytics, Hospital Pharmacies, Retail Pharmacies, ...

This research report (Global Fetal Alcohol Spectrum Disorder Treatment M) investigates and analyzes the current state and future outlook of the global market for fetal alcohol spectrum disorder (FASD) treatment over the next five years. It includes information on the global overview of the FASD treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the FASD treatment market by type include antidepressants, stimulants, muscle relaxants, and anxiolytics, while the segments by application focus on hospital pharmacies, retail pharmacies, drugstores, and e-commerce. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for FASD treatment. It also covers the market share of major companies in the FASD treatment sector, product and business overviews, sales performance, and more.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Anxiety Disorder and Depression Treatment Drugs

Global Market for Anxiety Disorders and Depression Treatment Drugs: SSRIs, SNRIs, TeCAs, TCAs, MAOIs, Atypical Antipsychotics, Benzodiazepines, Antidepressants...

This research report (Global Anxiety Disorders And Depression Therapeutic Drug Market) investigates and analyzes the current state and outlook for the global market of therapeutic drugs for anxiety disorders and depression over the next five years. It includes information on the overview of the global market for anxiety disorders and depression therapeutic drugs, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include SSRIs, SNRIs, TeCAs, TCAs, MAOIs, atypical antipsychotics, benzodiazepines, anticonvulsants, beta-blockers, and others, while the segments by application focus on major depressive disorder (MDD), obsessive-compulsive disorder (OCD), phobias, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for therapeutic drugs for anxiety disorders and depression. The report also includes the market share of major companies in the anxiety disorders and depression therapeutic drug market, product and business overviews, and sales performance, among other information.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration